Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Modi Ventures is a venture capital firm based in the United States, focusing on early-stage investments in the bioeconomy. The firm has a portfolio of 8 companies and targets sectors such as biotech and healthcare. Their investment strategy emphasizes technology platforms that positively impact health.
Modi Ventures invests in pre-seed to seed-plus stages, targeting funds and founders in biotech and healthcare. The firm is particularly interested in areas like artificial intelligence, microfluidics, multiomics, precision medicine, synthetic biology, gene editing, and living therapies. Check sizes are not specified, but the focus remains on early-stage technology platforms.
Notable portfolio companies include Proxima, which pioneers AI-driven drug discovery; Exciva Therapeutics, developing therapies for neuropsychiatric symptoms of dementia; Kamau Therapeutics, a clinical-stage gene correction company; and March Biosciences, focused on advanced cell therapies for complex diseases.
Submit your pitch through their form at modivc.com.
Modi Ventures typically participates in early-stage funding rounds, often leading investments in their target sectors.
The firm is open to follow-on investments, particularly in companies that demonstrate significant progress and alignment with their investment thesis.
Specific details about the fund size are not disclosed, but the firm focuses on early-stage investments in the bioeconomy.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.